Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis

Neurology
Jeremy ChatawayATX-MS1467 Study Group

Abstract

To assess safety, tolerability, and efficacy of the antigen-specific immunotherapy ATX-MS-1467 in participants with relapsing multiple sclerosis using different treatment protocols to induce tolerance. Two open-label trials in adult participants with relapsing multiple sclerosis were conducted. Study 1 was a multicenter, phase 1b safety evaluation comparing intradermal (i.d.) (cohort 1) with subcutaneous (cohort 2) administration in 43 participants. Both cohorts received ATX-MS-1467 dosed at 25, 50, 100, 400, and 800 μg at 14-day intervals over 8 weeks, followed by 8 weeks with 4 additional 800-μg doses at 14-day intervals and 32 weeks off study medication. Study 2 was a phase 2a, multicenter, single-arm trial enrolling 37 participants. ATX-MS-1467 was titrated from 50 μg i.d. on day 1 to 200 μg on day 15 and 800 μg on day 29 followed by biweekly administration of 800 μg for 16 weeks and 16 weeks off study medication. Efficacy was evaluated on MRI parameters and clinical variables. Safety endpoints included treatment-emergent adverse events and injection-site reactions. In study 1, there was a significant decrease in new/persisting T1 gadolinium-enhanced (GdE) lesions in cohort 1 from baseline to week 16, returning to baseline ...Continue Reading

References

Mar 20, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·M P SormaniM Filippi
Nov 29, 2001·Multiple Sclerosis : Clinical and Laboratory Research·M P SormanM Filipp
Jan 29, 2002·Nature Immunology·Stephen M AndertonDavid C Wraith
Apr 7, 2005·Nature Medicine·Mark Larché, David C Wraith
Jun 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Cassandra E SmithStephen D Miller
Nov 18, 2005·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Tom N Tombaugh
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Oct 7, 2011·Neurology·M S FreedmanUNKNOWN MAESTRO-01 Investigators
Jan 22, 2014·Journal of Internal Medicine·A H Cross, R T Naismith
Feb 4, 2014·Mayo Clinic Proceedings·Dean M Wingerchuk, Jonathan L Carter
Mar 29, 2014·Nature·Ken Garber
Sep 4, 2014·Nature Communications·Bronwen R BurtonDavid C Wraith
Mar 24, 2015·Neurology. Neuroimmunology and Neuroinflammation·Heather B StreeterDavid C Wraith
May 20, 2015·Clinical and Molecular Allergy : CMA·Carlo AgostiniEnrico Maggi
May 30, 2015·The World Allergy Organization Journal·Cezmi A Akdis, Mübeccel Akdis
Nov 8, 2015·Advanced Drug Delivery Reviews·Laura NorthrupCory Berkland

❮ Previous
Next ❯

Citations

Nov 20, 2018·Current Opinion in Nephrology and Hypertension·David J Salant
Jun 14, 2019·Thyroid : Official Journal of the American Thyroid Association·Simon H S PearceGeorge J Kahaly
Feb 6, 2020·Vaccines·Dejan JakimovskiRobert Zivadinov
Jun 4, 2020·Brain Sciences·Olga Kammona, Costas Kiparissides
Mar 12, 2019·Frontiers in Immunology·Anja Ten BrinkeEva Martinez-Caceres
Jul 4, 2020·Nature Reviews. Materials·C L StablerB G Keselowsky
Aug 15, 2020·Frontiers in Immunology·Naomi RichardsonDavid C Wraith
Apr 25, 2020·Frontiers in Physiology·Madeleine Iafrate, Gilbert O Fruhwirth
May 21, 2020·Brain Sciences·Athanasios MetaxakisNektarios Tavernarakis
Jul 4, 2018·CNS Drugs·Floriana De AngelisJeremy Chataway
Feb 26, 2019·Nature Biotechnology·Pau Serra, Pere Santamaria
Apr 17, 2020·Frontiers in Immunology·José M CarballidoMichael Kammüller
Mar 24, 2020·Brain, Behavior, and Immunity·Lindsey J CaldwellDivya K Shah
Apr 24, 2020·Advanced Drug Delivery Reviews·J Daniel GriffinCory J Berkland
Nov 3, 2020·Frontiers in Immunology·Laura Passerini, Silvia Gregori
Feb 3, 2021·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·David C Wraith, Mamidipudi T Krishna
Mar 9, 2021·Frontiers in Immunology·Judith DerdelinckxNathalie Cools
Apr 21, 2021·Current Opinion in Immunology·Heather B Streeter, David C Wraith
Jun 15, 2019·Clinical Therapeutics·John D Isaacs, Kundan Iqbal
Apr 4, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Candice Ashmore-HarrisGilbert O Fruhwirth
Aug 24, 2021·Frontiers in Immunology·Ranjeny ThomasSimi T Ahmed
Jan 30, 2021·European Thyroid Journal·Alan Chun Hong Lee, George J Kahaly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.